Filed: 11/14/2023ACC: 0000950123-23-010790
📋 What this filing means
YU FAN filed this quarterly 13F‑HR report disclosing 5 equity positions with a total reported market value of $1.41M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
5
Positions
$1.41M
Total AUM (reported)
720.03K
Total Shares
Allocation by class
COM$756.5K53.7%
COM SER A$503.3K35.7%
COMMON STOCK$137.9K9.8%
CLASS A ORD$12.1K0.9%
Portfolio Concentration
Top 3$1.26M89.4%
4–10$150.0K10.6%
Top 3 weight
89.4%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 720.03K
Sole
Full voting authority
720.03K
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole5
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings5
Rows:
SAGIMET BIOSCIENCES INC
SOLEShares57.19K
TypeSH
Market value$503.3K
35.70%
Sole
57.19K
Shared
0.00
None
0.00
SONENDO INC
SOLEShares547.95K
TypeSH
Market value$408.7K
28.99%
Sole
547.95K
Shared
0.00
None
0.00
CASTLE BIOSCIENCES INC
SOLEShares20.59K
TypeSH
Market value$347.8K
24.67%
Sole
20.59K
Shared
0.00
None
0.00
PYXIS ONCOLOGY INC
SOLEShares69.30K
TypeSH
Market value$137.9K
9.78%
Sole
69.30K
Shared
0.00
None
0.00
PRENETICS GLOBAL LTD
SOLEShares25K
TypeSH
Market value$12.1K
0.86%
Sole
25K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
SAGIMET BIOSCIENCES INCSOLE | COM SER A | 57.19K | SH | $503.3K 35.70% | 57.19K | 0.00 | 0.00 |
SONENDO INCSOLE | COM | 547.95K | SH | $408.7K 28.99% | 547.95K | 0.00 | 0.00 |
CASTLE BIOSCIENCES INCSOLE | COM | 20.59K | SH | $347.8K 24.67% | 20.59K | 0.00 | 0.00 |
PYXIS ONCOLOGY INCSOLE | COMMON STOCK | 69.30K | SH | $137.9K 9.78% | 69.30K | 0.00 | 0.00 |
PRENETICS GLOBAL LTDSOLE | CLASS A ORD | 25K | SH | $12.1K 0.86% | 25K | 0.00 | 0.00 |